standing of any disease process, in particular a complex one such as cancer, requires an exhaustive and consolidated multifacet attack by biologists, biochemists, biophysicists, virologists, chemists, immunologists, molecular biologists, nutritionists, and many others. Hence, the major aim of these Sardinian Meetings on Chemical Carcinogenesis was to gather experts in several fields related to carcinogenesis and try to achieve a synthesis.
The two most important facts that we ought to know are the nature of the etiologic agents that cause cancer and the manner in which cells respond to these agents. A large number of chemical carcinogens are hydrophobic and the major mechanism by which the cell gets rid of the intruding chemicals is by converting them to a hydrophilic derivative. Several experts in the field discussed the possible mechanisms, especially the monooxygenase systems, involved in such a process of detoxification.
It was clear from the discussion that in many of the systems geared for detoxification, some of the intermediates generated themselves to become good substrates for further activation, thus giving rise to derivatives which can now attack cellular components. Detoxification of dimethylnitrosamine and benzo(a)pyrene are two examples that support this statement. From the cellular viewpoint, it is unfortunate that these detoxification mechanisms are inadequate. We don't have an answer as to the reason for this inefficient way of handling xenobiotics by the cell. However, an analogy comes to my mind. When firemen come to put out a fire they do an excellent job in putting the fire out: but during the process, a few windows or doors are broken. Perhaps this is the price that we have to pay.
Once the active moiety is generated, it interacts with cellular constituents including DNA, one of the potential target molecules in the carcinogenic process. In some instances, the chemicals cause direct damage such as covalent (adduct formation) and non covalent (intercalation, etc.) interactions. In other instances, the chemicals can cause DNA damage in an indirect fashion such as those mediated by reactive oxygen species and free radicals. A full session was devoted to the genesis of the free radicals and how they effect cell physiology.
The various types of DNA damage and the subsequent repair at the level of DNA, chromosomes, and fibersomes and some of the mechanisms by which these processes may influence cell transformation and carcinogenic process were discussed. Also of considerable interest was the discussion on the role of cell proliferation and hypomethylation of DNA in the initiation process. In order to appreciate the significance of these data in the carcinogenic process, a large segment of this conference was devoted to the in vitro and in vivo models developed to understand the mechanisms of cell transformation and carcinogenic process. Several issues were raised concerning the differences between relevant versus irrelevant DNA lesions. Similarly, there was also a lively and useful discussion highlighting the relationship between preneoplastic and neoplastic lesions especially in the liver.
Since cell injury and growth are two of the key events intimately associated with the pathogenesis of the carcinogenic process, several speakers touched upon the possible mechanisms by which lipid peroxidation and glutathione play a role in cell injury. Likewise, the mechanisms by which tumor promoters influence tumor growth and the in-terplay between glucose-6-phosphate dehydrogenase, cholesterol synthesis, glycolipid and protein catabolism, and tumor growth and cell transformation were also discussed.
Certain key issues concerning the involvemen t of glucose-6-phospha te de hydrogenase in carcinogen activation, cell proliferation, and certain other cell physiologic aspects, such as hemolysis, were discussed.
The last session was devoted to a discussion on risk assessment. To assess the risk of a chemical, one needs to know the chemistry of the chemical and the response it elicits from the cell, as well as certain quantitative aspects in terms of duration and dose of exposure to the chemical. This is one of the most crucial requirements for a n accurate assessment of the risk posed by the chemical. Unfortunately, since in many instances this information is lacking and difficult to obtain, we can only learn about the carcinogenic potential of the chemical rather than the risk it poses. In essence, the chemistry of the etiologic agents and the nature of the response by the cell were discussed at length. Thus. the proceedings in general covered a wide range of topics beginning with what happens to the chemical after it gets into the cell through the development of cancer and ending with a discussion on risk assessment.
The pertinent question that most of us must be asking at this time is holv much progress have 'we made since we last met at Cagliari in 1981. It would appear that we did not make a lot of progress if we look ahead at the goal that we want to reach. But if we look back I am sure you all will.agree with-me that ivc did make significant progress.
I will be failing in my duty if I don't congratulate the organizers and the participants who made these two Sardinian meetings very successful. The proceedings of the first Sardinian Meeting, held in Cagliari in 1981 on "Xenobiotics and Biotransformation," was published in book form. The book can be obtained from Professor P. Pani, Istituto di Farmacologia e Patologia Biochimica, Universita di Cagliari, Via Procell-4, 09100 Cagliari, Italy. The proceedings of the 1983 Symposium are published in Toxicologic Pathology. In view of the amazing success of the past two meetings, the organizers decided to continue to hold these meetings once every 2 years. The Third Sardinian Meeting on Chemical Carcinogenesis will be held in Cagliari during October 1985. The Third Meeting will be on "Agents and Processes in Chemical Carcinogenesis."
